Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dig Dis Sci ; 58(7): 1880-90, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23543084

RESUMO

BACKGROUND: The X-ray repair cross-complementation group 1 (XRCC1) protein plays an important role in base excision repair. AIM: To elucidate the role of XRCC1 Arg399Gln, Arg194Trp and Arg280His genotypes in esophageal cancer risk, all available studies were considered in the present meta-analysis. METHODS: Eligible studies were identified by searching several electronic databases for relevant reports published before June 2012. RESULTS: According to the inclusion criteria and exclusion criteria, a total of 21 eligible studies were included in the pooled analyses. Among the 21 studies, 18 focused on Arg399Gln polymorphism, 11 described the Arg194Trp, and 4 articles investigated on Arg280His. Our analysis suggested that there was no evidence of significant association between XRCC1 Arg399Gln polymorphism and esophageal cancer risk in any genetic model. In the stratified analysis by ethnicity for Arg399Gln polymorphism and esophageal cancer, the results showed that Arg399Gln polymorphism was not associated with esophageal cancer risk. Only 4 studies analyzed the relationship between XRCC1 Arg280His polymorphism and the risk of esophageal cancer. The Arg/His and His/His genotypes were not significantly associated with increased risk of EC. A similar negative association was maintained in dominant and recessive models. However, for XRCC1 Arg194Trp polymorphism, our study showed individuals carrying the variant genotype Trp/Trp had a significant increased risk of esophageal cancer (OR = 1.295, 95 % CI 1.053-1.591, P = 0.014). In addition, increased associations were found in recessive model (OR = 1.332, 95 % CI 1.093-1.624, P = 0.005). CONCLUSIONS: Our meta-analysis suggested that Arg194Trp Trp allele might act as a risk allele in its association with esophageal cancer.


Assuntos
Adenocarcinoma/genética , Carcinoma de Células Escamosas/genética , Proteínas de Ligação a DNA/genética , Neoplasias Esofágicas/genética , Polimorfismo de Nucleotídeo Único , Adenocarcinoma/etnologia , Povo Asiático , Carcinoma de Células Escamosas/etnologia , Neoplasias Esofágicas/etnologia , Marcadores Genéticos , Humanos , Modelos Estatísticos , Fatores de Risco , População Branca , Proteína 1 Complementadora Cruzada de Reparo de Raio-X
2.
DNA Cell Biol ; 31(6): 1125-30, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22335768

RESUMO

Interleukin-8 (IL-8) belongs to the superfamily of CXC chemokines, contributing to human cancer progression through potential mitogenic, angiogenic, and motogenic functions. We hypothesize that the functional polymorphism of IL-8 may influence the inflammatory process during pathological stage from hepatitis to hepatocellular carcinoma (HCC). Two polymorphisms in the IL-8 gene (-251A/T and +781C/T) were examined in 160 cases of chronic hepatitis B, 80 cases of hepatitis B virus (HBV)-related liver cirrhosis (LC), 150 cases of HBV-related HCC, and 150 healthy controls using polymerase chain reaction-restriction fragment length polymorphism method and DNA sequencing. In the LC group, the AA genotypes were associated with a significantly decreased risk of LC compared with the TT genotype (OR=0.14, 95% CI 0.02-0.87, p=0.035). The data also revealed that subjects with the A allele appeared to have lower susceptibility to LC than those with the T allele (OR=0.48, 95% CI 0.25-0.92, p=0.027). The +781C/T polymorphism of IL-8 was not found relevant to the liver diseases. This study indicated that the IL-8 gene -251 AA genotype might be a protect factor for LC.


Assuntos
Predisposição Genética para Doença/genética , Vírus da Hepatite B/patogenicidade , Interleucina-8/genética , Hepatopatias/genética , Hepatopatias/virologia , Polimorfismo de Nucleotídeo Único , Adulto , Sequência de Bases , Estudos de Casos e Controles , Feminino , Frequência do Gene/genética , Haplótipos/genética , Hospitais , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...